Tavexia Lifecare Expands into Pharmaceuticals

Tavexia Lifecare Limited has announced its strategic expansion into the pharmaceutical business, establishing it as a new growth vertical. This move diversifies the company's revenue streams and strengthens its presence in the broader healthcare ecosystem, complementing its existing lifecare operations. The company plans to explore opportunities across the pharmaceutical value chain, including APIs, intermediates, and nutraceuticals. This expansion aligns with the robust growth projected for India's pharmaceutical market, which is expected to reach approximately US$130 billion by 2030. Tavexia aims to leverage this opportunity to build an additional growth engine and create long-term value for its stakeholders.